Suppression of interleukin-17-producing T-helper 17 cells by retinal pigment epithelial cells

Japanese Journal of Ophthalmology

Volumn 55, Issue 5, 2011, Pages 565-575

  Sugita, Sunao ^a   Horie, Shintaro ^a   Yamada, Yukiko ^a   Kawazoe, Yuko ^a   Takase, Hiroshi ^a   Mochizuki, Manabu ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Cytokine; Immune regulation; RPE cells; T cells; Th17 cells

Indexed keywords

INTERLEUKIN 17; RECOMBINANT INTERLEUKIN 6; RECOMBINANT TRANSFORMING GROWTH FACTOR BETA2; SMALL INTERFERING RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BYSTANDER EFFECT; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DNA MICROARRAY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HELPER CELL; IMMUNOMODULATION; MOUSE; NONHUMAN; PIGMENT EPITHELIUM; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE ACTIVATION; TH17 CELL; UVEITIS;

ANIMALS; AUTOIMMUNE DISEASES; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; COCULTURE TECHNIQUES; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; EYE PROTEINS; FLOW CYTOMETRY; IMMUNE TOLERANCE; INTERLEUKIN-17; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; REAL-TIME POLYMERASE CHAIN REACTION; RETINAL PIGMENT EPITHELIUM; RETINOL-BINDING PROTEINS; RNA, SMALL INTERFERING; SPLEEN; TH1 CELLS; TH17 CELLS; TH2 CELLS; TRANSFECTION; TRANSFORMING GROWTH FACTOR BETA; UVEITIS;

EID: 80054767681     PISSN: 00215155     EISSN: 16132246     Source Type: Journal    
DOI: 10.1007/s10384-011-0064-9     Document Type: Article

References (40)

1. E Bettelli Y Carrier W Gao T Korn TB Strom M Oukka, et al. 2006 Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells Nature 441 235 238 16648838 10.1038/nature04753 1:CAS:528:DC%2BD28XksVGns7g%3D
2. M Veldhoen RJ Hocking CJ Atkins RM Locksley B Stockinger 2006 TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells Immunity 24 179 189 16473830 10.1016/j.immuni.2006. 01.001 1:CAS:528:DC%2BD28XitVOks7s%3D (Pubitemid 43214587)
3. LE Harrington RD Hatton PR Mangan H Turner TL Murphy KM Murphy, et al. 2005 Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages Nat Immunol 6 1123 1132 16200070 10.1038/ni1254 1:CAS:528:DC%2BD2MXhtFamsb7J (Pubitemid 41541790)
4. LW Moreland JR Curtis 2009 Systemic nonarticular manifestations of rheumatoid arthritis: focus on inflammatory mechanisms Semin Arthritis Rheum 39 132 143 19022481 10.1016/j.semarthrit.2008.08.003 1:CAS:528:DC%2BD1MXht1WkurjO
5. S Fujino A Andoh S Bamba A Ogawa K Hata Y Araki, et al. 2003 Increased expression of interleukin 17 in inflammatory bowel disease Gut 52 65 70 12477762 10.1136/gut.52.1.65 1:CAS:528:DC%2BD3sXmtVyqsw%3D%3D (Pubitemid 36020767)
6. K Hamzaoui A Hamzaoui F Guemira M Bessioud M Hamza K Ayed 2002 Cytokine profile in Behcets disease patients. Relationship with disease activity Scand J Rheumatol 31 205 210 12369651 10.1080/030097402320318387 (Pubitemid 34971876)
7. W Chi P Yang B Li C Wu H Jin X Zhu, et al. 2007 IL-23 promotes CD4+ T cells to produce IL-17 in Vogt-Koyanagi-Harada disease J Allergy Clin Immunol 119 1218 1224 17335887 10.1016/j.jaci.2007.01.010 1:CAS:528:DC%2BD2sXksleku7o%3D (Pubitemid 46667160)
8. S Aggarwal N Ghilardi MH Xie FJ de Sauvage AL Gurney 2003 Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17 J Biol Chem 278 1910 1914 12417590 10.1074/jbc.M207577200 1:CAS:528:DC%2BD3sXisFyksA%3D%3D (Pubitemid 36801431)
9. JK Kolls A Linden 2004 Interleukin-17 family members and inflammation Immunity 21 467 476 15485625 10.1016/j.immuni.2004.08.018 1:CAS:528: DC%2BD2cXpvVygt7k%3D (Pubitemid 39370503)
10. I Lahmar A Abou-Bacar T Abdelrahman M Guinard H Babba S Ben Yahia, et al. 2009 Cytokine profiles in toxoplasmic and viral uveitis J Infect Dis 199 1239 1249 19302012 10.1086/597478 1:CAS:528:DC%2BD1MXltVOmsbo%3D
11. AF De Vos R Hoekzema A Kijlstra 1992 Cytokines and uveitis, a review Curr Eye Res 11 581 597 1505201 10.3109/02713689209001814
12. A Amadi-Obi CR Yu X Liu RM Mahdi GL Clarke RB Nussenblatt, et al. 2007 TH17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27/STAT1 Nat Med 13 711 718 17496900 10.1038/nm1585 1:CAS:528:DC%2BD2sXmtFeks7c%3D (Pubitemid 46889754)
13. T Yoshimura KH Sonoda Y Miyazaki Y Iwakura T Ishibashi A Yoshimura, et al. 2008 Differential roles for IFN-gamma and IL-17 in experimental autoimmune uveoretinitis Int Immunol 20 209 214 18156624 10.1093/intimm/dxm135 1:CAS:528:DC%2BD1cXhsVSgsbg%3D (Pubitemid 351234388)
14. T Yoshimura KH Sonoda N Ohguro Y Ohsugi T Ishibashi DJ Cua, et al. 2009 Involvement of Th17 cells and the effect of anti-IL-6 therapy in autoimmune uveitis Rheumatology (Oxford) 48 347 354 10.1093/rheumatology/ken489 1:CAS:528:DC%2BD1MXjsFeku7Y%3D
15. Y Cui H Shao C Lan H Nian RL OBrien WK Born, et al. 2009 Major role of gamma delta T cells in the generation of IL-17+ uveitogenic T cells J Immunol 183 560 567 19542467 10.4049/jimmunol.0900241 1:CAS:528:DC%2BD1MXnsVOqsLo%3D
16. J Tang W Zhu PB Silver SB Su CC Chan RR Caspi 2007 Autoimmune uveitis elicited with antigen-pulsed dendritic cells has a distinct clinical signature and is driven by unique effector mechanisms: initial encounter with autoantigen defines disease phenotype J Immunol 178 5578 5587 17442940 1:CAS:528: DC%2BD2sXktlWiurY%3D (Pubitemid 46674353)
17. S Sugita JW Streilein 2003 Iris pigment epithelium expressing CD86 (B7-2) directly suppresses T cell activation in vitro via binding to cytotoxic T lymphocyte-associated antigen 4 J Exp Med 198 161 171 12835481 10.1084/jem.20030097 1:CAS:528:DC%2BD3sXlsVersrs%3D (Pubitemid 36870196)
18. S Sugita TF Ng J Schwartzkopff JW Streilein 2004 CTLA-4+CD8+ T cells that encounter B7-2+ iris pigment epithelial cells express their own B7-2 to achieve global suppression of T cell activation J Immunol 172 4184 4194 15034031 1:CAS:528:DC%2BD2cXitlOqsb4%3D (Pubitemid 38375231)
19. S Sugita Y Futagami SB Smith H Naggar M Mochizuki 2006 Retinal and ciliary body pigment epithelium suppress activation of T lymphocytes via transforming growth factor beta Exp Eye Res 83 1459 1471 16996057 10.1016/j.exer.2006.08.005 1:CAS:528:DC%2BD28XhtFKmu7rF (Pubitemid 44648106)
20. S Sugita Y Usui S Horie Y Futagami H Aburatani, et al. 2009 T-cell suppression by programmed cell death 1 ligand 1 on retinal pigment epithelium during inflammatory conditions Invest Ophthalmol Vis Sci 50 2862 2870 19182257 10.1167/iovs.08-2846
21. Y Usui Y Okunuki T Hattori T Kezuka H Keino N Ebihara, et al. 2008 Functional expression of B7H1 on retinal pigment epithelial cells Exp Eye Res 86 52 59 17981268 10.1016/j.exer.2007.09.007 1:CAS:528:DC%2BD2sXhsVWjtb7L (Pubitemid 350212878)
22. Y Futagami S Sugita J Vega K Ishida H Takase K Maruyama, et al. 2007 Role of thrombospondin-1 in T cell response to ocular pigment epithelial cells J Immunol 178 6994 7005 17513749 1:CAS:528:DC%2BD2sXlsVOmt7k%3D (Pubitemid 46847426)
23. S Sugita S Horie O Nakamura Y Futagami H Takase H Keino, et al. 2008 Retinal pigment epithelium-derived CTLA-2alpha induces TGFbeta-producing T regulatory cells J Immunol 181 7525 7536 19017942 1:CAS:528:DC%2BD1cXhtl2gs7nF
24. S Sugita S Horie O Nakamura K Maruyama H Takase Y Usui, et al. 2009 Acquisition of T regulatory function in cathepsin L-inhibited T cells by eye-derived CTLA-2alpha during inflammatory conditions J Immunol 183 5013 5022 19801522 10.4049/jimmunol.0901623 1:CAS:528:DC%2BD1MXht1Whsb7I
25. S Sugita TF Ng PJ Lucas RE Gress JW Streilein 2006 B7+ iris pigment epithelium induce CD8+ T regulatory cells; both suppress CTLA-4+ T cells J Immunol 176 118 127 16365402 1:CAS:528:DC%2BD2MXhtlagt7bP (Pubitemid 43023255)
26. S Sugita 2009 Role of ocular pigment epithelial cells in immune privilege Arch Immunol Ther Exp (Warsz) 57 263 268 10.1007/s00005-009-0030-0
27. RR Caspi FG Roberge RB Nussenblatt 1987 Organ-resident, nonlymphoid cells suppress proliferation of autoimmune T-helper lymphocytes Science 237 1029 1032 2956685 10.1126/science.2956685 1:STN:280:DyaL2s3pt1Wgsg%3D%3D (Pubitemid 17131200)
28. SR Thurau CC Chan RB Nussenblatt RR Caspi 1997 Oral tolerance in a murine model of relapsing experimental autoimmune uveoretinitis (EAU): induction of protective tolerance in primed animals Clin Exp Immunol 109 370 376 9276535 10.1046/j.1365-2249.1997.4571356.x 1:STN:280:DyaK2svitVGmsg%3D%3D (Pubitemid 27308427)
29. D Avichezer PB Silver CC Chan B Wiggert RR Caspi 2000 Identification of a new epitope of human IRBP that induces autoimmune uveoretinitis in mice of the H-2b haplotype Invest Ophthalmol Vis Sci 41 127 131 10634611 1:STN:280:DC%2BD3c%2FpvVSquw%3D%3D (Pubitemid 30036558)
30. K Ishida N Panjwani Z Cao JW Streilein 2003 Participation of pigment epithelium in ocular immune privilege. 3. Epithelia cultured from iris, ciliary body, and retina suppress T-cell activation by partially non-overlapping mechanisms Ocul Immunol Inflamm 11 91 105 14533028 10.1076/ocii.11.2.91.15914 1:CAS:528:DC%2BD3sXotVektLc%3D (Pubitemid 37088581)
31. P Zamiri S Masli N Kitaichi AW Taylor JW Streilein 2005 Thrombospondin plays a vital role in the immune privilege of the eye Invest Ophthalmol Vis Sci 46 908 919 15728547 10.1167/iovs.04-0362 (Pubitemid 41321027)
32. H Wenkel JW Streilein 2000 Evidence that retinal pigment epithelium functions as an immune-privileged tissue Invest Ophthalmol Vis Sci 41 3467 3473 11006240 1:STN:280:DC%2BD3cvot1ygtA%3D%3D
33. H Takase Y Futagami T Yoshida K Kamoi S Sugita Y Imai, et al. 2006 Cytokine profile in aqueous humor and sera of patients with infectious or noninfectious uveitis Invest Ophthalmol Vis Sci 47 1557 1561 16565392 10.1167/iovs.05-0836 (Pubitemid 46780765)
34. K Ohta S Yamagami AW Taylor JW Streilein 2000 IL-6 antagonizes TGF-beta and abolishes immune privilege in eyes with endotoxin-induced uveitis Invest Ophthalmol Vis Sci 41 2591 2599 10937571 1:STN:280:DC%2BD3czps1ajtA%3D%3D (Pubitemid 30624387)
35. W Chen W Jin N Hardegen KJ Lei L Li N Marinos, et al. 2003 Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3 J Exp Med 198 1875 1886 14676299 10.1084/jem.20030152 1:CAS:528:DC%2BD3sXpvFaktLg%3D (Pubitemid 38032120)
36. RD Granstein R Staszewski TL Knisely E Zeira R Nazareno M Latina DM Albert 1990 Aqueous humor contains transforming growth factor-beta and a small (less than 3500 daltons) inhibitor of thymocyte proliferation J Immunol 144 3021 3027 2324494 1:CAS:528:DyaK3cXitlekur8%3D (Pubitemid 20149474)
37. DT Nardelli MA Burchill DM England J Torrealba SM Callister RF Schell 2004 Association of CD4+CD25+ T cells with prevention of severe destructive arthritis in Borrelia burgdorferi-vaccinated and challenged gamma interferon-deficient mice treated with anti-interleukin-17 antibody Clin Diagn Lab Immunol 11 1075 1084 15539509 1:CAS:528:DC%2BD2cXhtFShsrrO (Pubitemid 39540847)
38. EB Samoilova JL Horton B Hilliard TS Liu Y Chen 1998 IL-6-deficient mice are resistant to experimental autoimmune encephalomyelitis: roles of IL-6 in the activation and differentiation of autoreactive T cells J Immunol 161 6480 6486 9862671 1:CAS:528:DyaK1cXotFWqs7c%3D (Pubitemid 28562184)
39. Y Peng G Han H Shao Y Wang HJ Kaplan D Sun 2007 Characterization of IL-17+ interphotoreceptor retinoid-binding protein-specific T cells in experimental autoimmune uveitis Invest Ophthalmol Vis Sci 48 4153 4161 17724201 10.1167/iovs.06-1189 (Pubitemid 351261292)
40. R Zhang J Qian J Guo YF Yuan K Xue 2009 Suppression of experimental autoimmune uveoretinitis by Anti-IL-17 antibody Curr Eye Res 34 297 303 19373578 10.1080/02713680902741696